Annual Retained Earnings
-$66.90 M
-$19.03 M-39.75%
December 31, 2023
Summary
- As of February 7, 2025, IKT annual retained earnings is -$66.90 million, with the most recent change of -$19.03 million (-39.75%) on December 31, 2023.
- During the last 3 years, IKT annual retained earnings has fallen by -$51.87 million (-345.07%).
- IKT annual retained earnings is now -935.50% below its all-time high of -$6.46 million, reached on December 31, 2018.
Performance
IKT Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$82.29 M
-$5.78 M-7.55%
September 30, 2024
Summary
- As of February 7, 2025, IKT quarterly retained earnings is -$82.29 million, with the most recent change of -$5.78 million (-7.55%) on September 30, 2024.
- Over the past year, IKT quarterly retained earnings has dropped by -$5.78 million (-7.55%).
- IKT quarterly retained earnings is now -575.39% below its all-time high of -$12.18 million, reached on December 31, 2019.
Performance
IKT Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
IKT Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -39.8% | -7.5% |
3 y3 years | -345.1% | -57.2% |
5 y5 years | -935.5% | -57.2% |
IKT Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -124.4% | at low | -176.0% | at low |
5 y | 5-year | -449.1% | at low | -575.4% | at low |
alltime | all time | -935.5% | at low | -575.4% | at low |
Inhibikase Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$82.29 M(+7.6%) |
Jun 2024 | - | -$76.51 M(+6.9%) |
Mar 2024 | - | -$71.55 M(+7.0%) |
Dec 2023 | -$66.90 M(+39.7%) | -$66.90 M(+6.7%) |
Sep 2023 | - | -$62.72 M(+7.9%) |
Jun 2023 | - | -$58.13 M(+11.0%) |
Mar 2023 | - | -$52.35 M(+9.4%) |
Dec 2022 | -$47.87 M | -$47.87 M(+9.8%) |
Sep 2022 | - | -$43.59 M(+11.5%) |
Jun 2022 | - | -$39.10 M(+13.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | -$34.46 M(+15.6%) |
Dec 2021 | -$29.82 M(+98.4%) | -$29.82 M(+20.3%) |
Sep 2021 | - | -$24.78 M(+22.0%) |
Jun 2021 | - | -$20.30 M(+14.9%) |
Mar 2021 | - | -$17.67 M(+17.5%) |
Dec 2020 | -$15.03 M(+23.4%) | -$15.03 M(+8.7%) |
Sep 2020 | - | -$13.82 M(+5.1%) |
Jun 2020 | - | -$13.15 M(+3.3%) |
Mar 2020 | - | -$12.73 M(+4.5%) |
Dec 2019 | -$12.18 M(+88.6%) | -$12.18 M |
Dec 2018 | -$6.46 M | - |
FAQ
- What is Inhibikase Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics annual retained earnings year-on-year change?
- What is Inhibikase Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics quarterly retained earnings year-on-year change?
What is Inhibikase Therapeutics annual retained earnings?
The current annual retained earnings of IKT is -$66.90 M
What is the all time high annual retained earnings for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual retained earnings is -$6.46 M
What is Inhibikase Therapeutics annual retained earnings year-on-year change?
Over the past year, IKT annual retained earnings has changed by -$19.03 M (-39.75%)
What is Inhibikase Therapeutics quarterly retained earnings?
The current quarterly retained earnings of IKT is -$82.29 M
What is the all time high quarterly retained earnings for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly retained earnings is -$12.18 M
What is Inhibikase Therapeutics quarterly retained earnings year-on-year change?
Over the past year, IKT quarterly retained earnings has changed by -$5.78 M (-7.55%)